TRUGENE HIV-1 GUIDELINES RULES 12.0 & 11.0 12.0 / 11.0 06548414/06246360

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 07 report with the FDA on 2008-07-09 for TRUGENE HIV-1 GUIDELINES RULES 12.0 & 11.0 12.0 / 11.0 06548414/06246360 manufactured by Siemens Healthcare Diagnostics.

Event Text Entries

[880521] A customer reported a discrepancy on the interpretation of atazanavir/atazanavir+ ritonavir on trugene guidelines 12. 0. The trugene guidelines rules versions 12. 0 and 11. 0 do not provide an adequate indication of resistance levels for atazanavir (atv) in the absence of ritonavir for all mutation profiles. The indication of resistance should not be lower for unboosted atv than the indication for atv when boosted with ritonavir (atv/r) on the trugene resistance report. There has been no report of adverse health consequences as a result of the missing rule.
Patient Sequence No: 1, Text Type: D, B5


[8069025] Trugene guidelines rules 11. 0 and 12. 0 for trugene genotyping kit and opengene dna sequencing system are developed by a consensus panel of leading experts in the field of resistance using relevant data presented at scientific symposia and published in peer reviewed journals. During the investigation of this problem, we found that a rule of unboosted atv was not added for all the mutational profiles associated with possible resistance or resistance to boosted atv (atv/r) when the mutational profiles and associated resistance to atv/r was added to guidelines 11. 0 and carried forward to guidelines 12. 0. A rule for atv in the absence of ritonavir will be added to mutational profiles associated with resistance or possible resistance to atv/r with the next guidelines rules revisions.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3003932969-2008-00001
MDR Report Key1077066
Report Source07
Date Received2008-07-09
Date of Report2008-06-25
Date of Event2008-06-20
Date Mfgr Received2008-06-25
Device Manufacturer Date2007-05-15
Date Added to Maude2009-05-12
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactSONIA STEWART
Manufacturer Street725 POTTER STREET
Manufacturer CityBERKELEY CA 94710
Manufacturer CountryUS
Manufacturer Postal94710
Manufacturer Phone3026316951
Manufacturer G1SPARTON MEDICAL SYSTEMS
Manufacturer Street22740 LUNN ROAD
Manufacturer CitySTRONGSVILLE OH 44149
Manufacturer CountryUS
Manufacturer Postal Code44149
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameTRUGENE HIV-1 GUIDELINES RULES 12.0 & 11.0
Generic NameIN VITRO HIV DRUG RESISTANCE GENOTYPE
Product CodeNHS
Date Received2008-07-09
Model Number12.0 / 11.0
Catalog Number06548414/06246360
Lot NumberNA
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeNA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS
Manufacturer AddressTARRYTOWN NY 10591 US 10591


Patients

Patient NumberTreatmentOutcomeDate
10 2008-07-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.